Fundraising September 15, 2024 – October 1, 2024 About fundraising

Avelumab (anti-PD-L1) in platinum-resistant/refractory...

  • Main
  • 2018 / 03
  • Avelumab (anti-PD-L1) in platinum-resistant/refractory...

Avelumab (anti-PD-L1) in platinum-resistant/refractory ovarian cancer: JAVELIN Ovarian 200 Phase III study design

Pujade-Lauraine, Eric, Fujiwara, Keiichi, Dychter, Samuel S, Devgan, Geeta, Monk, Bradley J
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
Future Oncology
DOI:
10.2217/fon-2018-0070
Date:
March, 2018
File:
PDF, 1.59 MB
english, 2018
Conversion to is in progress
Conversion to is failed